Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 76 (PPIAP76)

Target: PPIAP76
Molecular classification: Other (Pseudogene)

Overview

Peptidylprolyl isomerase A pseudogene 76 (PPIAP76) is classified as a pseudogene related to the *peptidylprolyl isomerase A* gene[1][2]. Pseudogenes are typically non-coding genomic sequences similar to known genes but are considered non-functional because they carry mutations preventing them from encoding functional proteins. There is no evidence that PPIAP76 encodes a protein product or acts as a therapeutic target. Therefore, PPIAP76 is not a receptor, enzyme, or druggable human protein, and should not be considered a therapeutic target. It is distinct from the canonical functional gene *peptidylprolyl isomerase A* (PPIA, also known as cyclophilin A)[3][4].

Other names: PPIAP76

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 76 (PPIAP76).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 76 (PPIAP76).

Explore the full profile